Glenmark Pharmaceuticals ltd — Share Issue/Capital Change 2025

Apr 17, 2025

==> picture [34 x 32] intentionally omitted <==

==> picture [149 x 44] intentionally omitted <==

April 17, 2025

To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, The National Stock Exchange of India Ltd., BSE Ltd. Plot No. C/1, G Block Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051

Ref: Scrip Code: 532296 Ref: Scrip Name: GLENMARK

Dear Sir,

Sub: Allotment of equity shares under the Glenmark Pharmaceuticals Limited Employee Stock Option Scheme, 2016

We would like to inform you that, the Operations Committee of the Company at its meeting held on April 17, 2025 has approved the allotment of 12,653 equity shares of face value of Re. 1/- each to the eligible employee who has exercised stock options under the Glenmark Pharmaceuticals Limited - Employee Stock Option Scheme, 2016 (“ESOP 2016”).

Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased as under:

nder:
From	To
28,21,88,156 equity shares of Re. 1 each aggregatingto Rs. 28,21,88,156/-	28,22,00,809 equity shares of Re. 1 each aggregatingto Rs. 28,22,00,809/-

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Glenmark Pharmaceuticals Limited

HARISH Digitally signed by HARISH VINAYA VINAYAK KUBER Date: 2025.04.17 K KUBER 16:57:44 +05'30'

Harish Kuber Company Secretary & Compliance Officer

Encl: As above

Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com

==> picture [34 x 32] intentionally omitted <==

==> picture [149 x 44] intentionally omitted <==

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Regulations, 2021
Company Name and address of Registered Office	Glenmark Pharmaceuticals Limited Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026
Name of the Stock Exchanges on which the Company’s shares are listed	1) BSE Limited 2) The National Stock Exchange of India Limited
Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations,2021 with Stock Exchange	September 6, 2016
Filing Number, if any	In-Principle Approval Letter: BSE: DCS/IPO/ST/ESOP-IP/1319/2016-17 NSE: NSE/LIST/88702
Title of the Scheme pursuant to which shares are issued,if any	Glenmark Pharmaceuticals Limited - Employee Stock Option Scheme,2016
Kind of securityto be listed	EquityShares
Par value of the shares	1
Date of issue of shares	April 17, 2025 (Date of allotment on exercise)
Number of shares issued	12,653
Share Certificate No.,if applicable	Not applicable
Distinctive number of the share,if applicable	282188157 - 282200809
ISIN Number of the shares if issued in Demat	INE935A01035
Exercisepriceper share	600
Premiumper share	599
Total Issued shares after this issue	28,22,00,809
Total Issued share capital after this issue	Rs. 28,22,00,809
Details of anylock-in on the shares	Not applicable
Date of expiryof lock-in	Not applicable
Whether shares identical in all respects to existing shares if not,when will theybecome identical?	Yes, the shares rank pari passu with the existingshares
Details of listingfees,ifpayable	Not applicable

Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com